Prevenar 20 is a vaccine to protect adults and children from 6 weeks of age against pneumonia (infection of the lungs) and invasive diseases (diseases that occur when a bacterium spreads through the body) caused by the bacterium Streptococcus pneumoniae (S. pneumoniae). It is also used in children from 6 weeks to 17 years of age to protect against acute otitis media (ear infection). Prevenar 20 contains parts from 20 different types of S. pneumoniae.
Therapeutic Indication
### Therapeutic indication Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years of age and older. See sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes. Apexxnar should be used in accordance with official recommendations.
Therapeutic Area (MeSH)
N/AATC Code
J07AL02
ATC Item
pneumococcus, purified polysaccharides antigen conjugated
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
N/AINN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| Pneumococcal polysaccharide serotype 1 | N/A | pneumococcal polysaccharide serotype 1 |
| Pneumococcal polysaccharide serotype 3 | N/A | pneumococcal polysaccharide serotype 3 |
| Pneumococcal polysaccharide serotype 4 | N/A | Streptococcus pneumoniae type 4 capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 5 | N/A | pneumococcal polysaccharide serotype 5 |
| Pneumococcal polysaccharide serotype 6A | N/A | Streptococcus pneumoniae type 6a capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 6B | N/A | Streptococcus pneumoniae type 6b capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 7F | N/A | pneumococcal polysaccharide serotype 7 f |
| Pneumococcal polysaccharide serotype 8 | N/A | pneumococcal polysaccharide serotype 8 |
| Pneumococcal polysaccharide serotype 9V | N/A | Streptococcus pneumoniae type 9v capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 10A | N/A | pneumococcal polysaccharide serotype 10 a |
| Pneumococcal polysaccharide serotype 11A | N/A | pneumococcal polysaccharide serotype 11 a |
| pneumococcal polysaccharide serotype 12F | N/A | pneumococcal polysaccharide serotype 12 f |
| Pneumococcal polysaccharide serotype 14 | N/A | Streptococcus pneumoniae type 14 capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 15b | N/A | pneumococcal polysaccharide serotype 15 b |
| Pneumococcal polysaccharide serotype 18C | N/A | Streptococcus pneumoniae type 18c capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 19A | N/A | pneumococcal polysaccharide serotype 19 a |
| Pneumococcal polysaccharide serotype 19F | N/A | Streptococcus pneumoniae type 19f capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 22F | N/A | pneumococcal polysaccharide serotype 22 f |
| Pneumococcal polysaccharide serotype 23F | N/A | Streptococcus pneumoniae type 23f capsular polysaccharide antigen |
| Pneumococcal polysaccharide serotype 33F | N/A | pneumococcal polysaccharide serotype 33 f |
EMA Name
Prevenar 20 (previously Apexxnar)
Medicine Name
Prevenar 20 (previously Apexxnar)
Aliases
N/ANo risk management plan link.
